Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 4/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | RARB | P10826 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10498226 | 0.94 | PRKCA (0.39) | PRKCAGAANPSR1POLBBLM | |
| SCHEMBL29467087 | 0.92 | PRKCA (0.38) | PRKCAGAANPSR1POLBBLM | |
| SCHEMBL29365868 | 0.92 | PRKCA (0.38) | PRKCAGAANPSR1POLBBLM | |
| SCHEMBL22830548 | 0.92 | PRKCA (0.38) | PRKCAGAANPSR1POLBBLM | |
| SCHEMBL28378738 | 0.92 | PRKCA (0.38) | PRKCAGAANPSR1POLBBLM | |
| SCHEMBL24652860 | 0.92 | PRKCA (0.38) | PRKCAGAANPSR1POLBBLM | |
| SCHEMBL3323623 | 0.92 | PRKCA (0.38) | PRKCAGAANPSR1POLBBLM | |
| SCHEMBL2523056 | 0.92 | PRKCA (0.38) | PRKCAGAANPSR1POLBBLM | |
| SCHEMBL4672637 | 0.88 | BLM (0.35) | GAANPSR1BLMMMP8PTPN1 | |
| Pivalate SCHEMBL1639290 | 0.87 | ACACB (0.40) | PRKCAGAANPSR1POLBBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1003 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025133193-A1 | COSMETIC COMPOSITION OF THE OIL-IN-WATER EMULSION TYPE, HAVING A POWDERY PERCEPTION | L'OREAL (FR) | 2025-06-26 | — | — | WO | claimed |
| CN-111601580-B | Solid anhydrous composition comprising a hydrophobic polymer for removing make-up from the skin | 莱雅公司 | 2023-09-05 | — | — | CN | claimed |
| CN-115867250-A | Skin tightening cosmetic compositions and methods of use | 莱雅公司 | 2023-03-28 | — | — | CN | claimed |
| CN-111601580-A | Solid anhydrous composition for removing color cosmetics on skin comprising hydrophobic polymers | 莱雅公司 | 2020-08-28 | — | — | CN | claimed |
| CN-110730653-A | Cosmetic composition comprising pullulan derivative | LVMH研究公司 | 2020-01-24 | — | — | CN | claimed |
| CN-106852117-A | Solid anhydrous composition for removing make-up from the skin | 莱雅公司 | 2017-06-13 | — | — | CN | claimed |
| CN-102666665-B | Silicone compositions comprising a swollen silicone gel | DOW CORNING | 2015-07-22 | — | — | CN | claimed |
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2026-05-28 | — | — | US | disclosed |
| US-20260144737-A1 | Care and/or Make-Up Composition for Keratin Materials Comprising at Least One Volatile Solvent, a Particular Polyester and a Colorant | L'OREAL (FR) | 2026-05-28 | — | — | US | disclosed |
| EP-4743054-A1 | EYEBROW MAKE-UP COMPOSITION WITH A NON-GLYCEROLATED SILICONE RESIN, A GLYCEROLATED SILICONE RESIN, A SILICONE GUM, A VOLATILE HYDROCARBON OIL AND A THICKENER | L'OREAL (FR) | 2026-05-20 | — | — | EP | disclosed |
| EP-4077339-B1 | CATALYST PARTICLES AND METHODS FOR DEHYDROGENATIVE SILYLATION | DOW SILICONES CORP (US) | 2026-05-13 | — | — | EP | disclosed |
| US-12616647-B2 | Non-pulverulent antisun composition comprising a polar oil phase and hydrophobic silica aerogel particles | L'OREAL (FR) | 2026-05-05 | — | — | US | disclosed |
| EP-4731172-A2 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE NATURAL RESIN AND A CRYSTALLIZABLE FATTY SUBSTANCE | L'OREAL (FR) | 2026-04-29 | — | — | EP | disclosed |
| CN-104263454-A | Traction fluid composition | ASHLAND LICENSING & INTELLECTU | 2015-01-07 | — | — | CN | disclosed |
| CN-104207963-A | decorative cosmetic composition | BAYER MATERIALSCIENCE AG | 2014-12-17 | — | — | CN | disclosed |
| US-20140134262-A1 | METHOD OF TREATING ATHEROSCLEROSIS IN HIGH TRIGLYCERIDE SUBJECTS | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. | 2014-05-15 | — | — | US | disclosed |
| US-7691538-B2 | Nonaqueous electrolyte secondary battery | SANYO ELECTRIC CO., LTD. (JP) | 2010-04-06 | — | — | US | disclosed |
| US-20080241702-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | SANYO ELECTRIC CO., LTD. (JP) | 2008-10-02 | — | — | US | disclosed |
| CN-1658821-A | cosmetic composition comprising at least one silicone-based polyamide | OREAL (FR) | 2005-08-24 | — | — | CN | disclosed |
| CN-1386490-A | Composition based on silicone oil structurized in hardened form, especially use in beauty cosmetics | OREAL (FR) | 2002-12-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144737-A1 | Care and/or Make-Up Composition for Keratin Materials Comprising at Least One Volatile Solvent, a Particular Polyester and a Colorant | KRT18, FGB, CUTA | PRKCA 152/4885GAA 4644/4885NPSR1 4754/4885 |
| US-20140134262-A1 | METHOD OF TREATING ATHEROSCLEROSIS IN HIGH TRIGLYCERIDE SUBJECTS | CETP, MTTP, APOB | PRKCA 798/4885GAA 624/4885NPSR1 2476/4885 |
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | HAO2, HADH, LDHA | PRKCA 1015/4885GAA 1401/4885NPSR1 4439/4885 |
| US-12616647-B2 | Non-pulverulent antisun composition comprising a polar oil phase and hydrophobic silica aerogel particles | SMURF1, EBP, SPTLC3 | PRKCA 1516/4885GAA 4164/4885NPSR1 3688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.